Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Radiat Res. 2011 Jan 11;175(4):444–451. doi: 10.1667/RR2317.1

FIG. 2.

FIG. 2

AZD1152 induces G2/M and polyploidy cell cycle arrest in PC3 and DU145 prostate cancer cells in a dose-responsive and treatment-time-responsive manner. Panel A: PC3 and DU145 cells were treated with increasing concentrations of AZD1152 for 48 h. Panel B: PC3 cells and DU145 cells were treated 60 nM AZD1152 for increasing treatment durations. Cell numbers in each of the cell cycle phases were determined using flow cytometry.